Johan Bratt

Area of research

Rheumatology · Immunology

Research interest

Research interests include Rheumatoid Arthritis Research and Therapies, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Cell Adhesion Molecules Research, and Spondyloarthritis Studies and Treatments.

h-index

citations

1,907

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial

Annals of the Rheumatic Diseases 2014cited by 49position: middledoi

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

The Lancet 2012cited by 223position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Ingemar F. Petersson · Lund University2 papers (2012–2014)Sofia Ernestam · Stockholm Health Care Services2 papers (2012–2014)Pierre Geborek · Lund University2 papers (2012–2014)Ronald van Vollenhoven · Amsterdam Neuroscience2 papers (2012–2014)Martin Neovius · University of Hawaiʻi at Mānoa1 papers (2014–2014)Jonas Eriksson · Karolinska Institutet1 papers (2014–2014)Johan Karlsson · University of Florida1 papers (2014–2014)— · 1 papers (2012–2012)Katerina Chatzidionysiou · Karolinska University Hospital1 papers (2012–2012)Kristina Forslind · Lund University1 papers (2012–2012)